IL123124A0 - Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors - Google Patents
Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitorsInfo
- Publication number
- IL123124A0 IL123124A0 IL12312497A IL12312497A IL123124A0 IL 123124 A0 IL123124 A0 IL 123124A0 IL 12312497 A IL12312497 A IL 12312497A IL 12312497 A IL12312497 A IL 12312497A IL 123124 A0 IL123124 A0 IL 123124A0
- Authority
- IL
- Israel
- Prior art keywords
- bicyclic
- tyrosine kinase
- kinase inhibitors
- aralkylaminopyrimidine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9613021.6A GB9613021D0 (en) | 1996-06-21 | 1996-06-21 | Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
PCT/EP1997/002965 WO1997049689A1 (en) | 1996-06-21 | 1997-06-03 | Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
IL123124A0 true IL123124A0 (en) | 1998-09-24 |
Family
ID=10795666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12312497A IL123124A0 (en) | 1996-06-21 | 1997-06-03 | Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
Country Status (20)
Country | Link |
---|---|
US (1) | US6057326A (zh) |
EP (1) | EP0853616B1 (zh) |
JP (1) | JPH11511761A (zh) |
KR (1) | KR19990043993A (zh) |
CN (1) | CN1198158A (zh) |
AR (1) | AR008614A1 (zh) |
AT (1) | ATE205836T1 (zh) |
AU (1) | AU3094197A (zh) |
BR (1) | BR9702328A (zh) |
CA (1) | CA2228492C (zh) |
DE (1) | DE69706823T2 (zh) |
EA (1) | EA199800215A1 (zh) |
ES (1) | ES2165061T3 (zh) |
GB (1) | GB9613021D0 (zh) |
HU (1) | HUP9902026A3 (zh) |
IL (1) | IL123124A0 (zh) |
NO (1) | NO980718L (zh) |
PL (1) | PL325122A1 (zh) |
WO (1) | WO1997049689A1 (zh) |
ZA (1) | ZA975380B (zh) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6347480B1 (en) * | 1997-07-07 | 2002-02-19 | Southpac Trust International, Inc. | Method for wrapping a floral grouping with a sheet of material constructed of paper and having printed and embossed patterns thereon |
IL125686A (en) | 1996-02-13 | 2002-11-10 | Zeneca Ltd | Quinazoline derivatives, processes for their preparation, pharmaceutical preparations containing them and their use in the manufacture of a drug with an anti-angiogenic effect and / or an effect of reducing vascular permeability |
WO1997032856A1 (en) | 1996-03-05 | 1997-09-12 | Zeneca Limited | 4-anilinoquinazoline derivatives |
GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
US6608060B1 (en) | 1996-12-18 | 2003-08-19 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
US6147080A (en) * | 1996-12-18 | 2000-11-14 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
US5945418A (en) * | 1996-12-18 | 1999-08-31 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
DE19653646A1 (de) * | 1996-12-20 | 1998-06-25 | Hoechst Ag | Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung |
EP1230225A2 (en) * | 1999-11-01 | 2002-08-14 | Eli Lilly And Company | Pharmaceutically active 4-substituted pyrimidine derivatives |
IL149034A0 (en) | 1999-11-05 | 2002-11-10 | Astrazeneca Ab | Quinazoline derivatives as vegf inhibitors |
US20040235867A1 (en) * | 2001-07-24 | 2004-11-25 | Bilodeau Mark T. | Tyrosine kinase inhibitors |
KR100468352B1 (ko) * | 2002-09-24 | 2005-01-27 | 한국과학기술연구원 | 신규 피라졸로피리미딘계 유도체, 그의 제조방법 및 이를 유효성분으로 하는 약학적 조성물 |
US20050124637A1 (en) * | 2003-08-15 | 2005-06-09 | Irm Llc | Compounds and compositions as inhibitors of receptor tyrosine kinase activity |
ES2554330T3 (es) * | 2004-02-19 | 2015-12-18 | Rexahn Pharmaceuticals, Inc. | Derivados de quinazolina y uso terapéutico de los mismos |
US7151176B2 (en) * | 2004-10-21 | 2006-12-19 | Bristol-Myers Squibb Company | Pyrrolotriazine compounds |
WO2006104971A1 (en) * | 2005-03-28 | 2006-10-05 | Bristol-Myers Squibb Company | Atp competitive kinase inhibitors |
JP5781934B2 (ja) * | 2008-11-10 | 2015-09-24 | ナショナル ヘルス リサーチ インスティテューツ | チロシンキナーゼ阻害剤としての融合2環および3環ピリミジン化合物 |
UA110113C2 (xx) * | 2010-07-29 | 2015-11-25 | Біциклічні азагетероциклічні карбоксаміди | |
EP2655374B1 (en) * | 2010-12-20 | 2019-10-23 | Incyte Holdings Corporation | N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL89028A0 (en) * | 1988-01-29 | 1989-08-15 | Lilly Co Eli | Quinoline,quinazoline and cinnoline derivatives |
ZA902280B (en) * | 1989-03-29 | 1990-12-28 | Merrell Dow Pharma | Selective adenosine receptor agents |
JP2762430B2 (ja) * | 1991-01-18 | 1998-06-04 | 宇部興産株式会社 | アラルキルアミノピリミジン類の製法 |
US5710158A (en) * | 1991-05-10 | 1998-01-20 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
JPH06172321A (ja) * | 1992-10-08 | 1994-06-21 | Agro Kanesho Co Ltd | 置換アミノピリミジン誘導体、その製造法及びそれを有効成分とする有害生物駆除剤 |
GB9313638D0 (en) * | 1993-07-01 | 1993-08-18 | Erba Carlo Spa | Arylidene and heteroarylidene oxindole derivatives and process for their preparation |
GB9326136D0 (en) * | 1993-12-22 | 1994-02-23 | Erba Carlo Spa | Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents |
IL112249A (en) * | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
GB9406137D0 (en) * | 1994-03-28 | 1994-05-18 | Erba Carlo Spa | N-substituted beta-aryl- and betaheteroaryl-alpha-cyanoacrylamide derivatives and process for their preparation |
GB9412719D0 (en) * | 1994-06-24 | 1994-08-17 | Erba Carlo Spa | Substituted azaindolylidene compounds and process for their preparation |
GB9423997D0 (en) * | 1994-11-28 | 1995-01-11 | Erba Carlo Spa | Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation |
-
1996
- 1996-06-21 GB GBGB9613021.6A patent/GB9613021D0/en active Pending
-
1997
- 1997-06-03 DE DE69706823T patent/DE69706823T2/de not_active Expired - Fee Related
- 1997-06-03 WO PCT/EP1997/002965 patent/WO1997049689A1/en not_active Application Discontinuation
- 1997-06-03 BR BR9702328A patent/BR9702328A/pt not_active Application Discontinuation
- 1997-06-03 US US09/000,238 patent/US6057326A/en not_active Expired - Fee Related
- 1997-06-03 EP EP97925987A patent/EP0853616B1/en not_active Expired - Lifetime
- 1997-06-03 IL IL12312497A patent/IL123124A0/xx unknown
- 1997-06-03 JP JP10502193A patent/JPH11511761A/ja not_active Ceased
- 1997-06-03 PL PL97325122A patent/PL325122A1/xx unknown
- 1997-06-03 CN CN97190942A patent/CN1198158A/zh active Pending
- 1997-06-03 HU HU9902026A patent/HUP9902026A3/hu unknown
- 1997-06-03 AT AT97925987T patent/ATE205836T1/de not_active IP Right Cessation
- 1997-06-03 AU AU30941/97A patent/AU3094197A/en not_active Abandoned
- 1997-06-03 ES ES97925987T patent/ES2165061T3/es not_active Expired - Lifetime
- 1997-06-03 KR KR1019980701225A patent/KR19990043993A/ko not_active Application Discontinuation
- 1997-06-03 CA CA002228492A patent/CA2228492C/en not_active Expired - Fee Related
- 1997-06-03 EA EA199800215A patent/EA199800215A1/ru unknown
- 1997-06-18 ZA ZA9705380A patent/ZA975380B/xx unknown
- 1997-06-20 AR ARP970102715A patent/AR008614A1/es unknown
-
1998
- 1998-02-20 NO NO980718A patent/NO980718L/no unknown
Also Published As
Publication number | Publication date |
---|---|
US6057326A (en) | 2000-05-02 |
ATE205836T1 (de) | 2001-10-15 |
NO980718D0 (no) | 1998-02-20 |
ES2165061T3 (es) | 2002-03-01 |
KR19990043993A (ko) | 1999-06-25 |
BR9702328A (pt) | 1999-07-20 |
CA2228492A1 (en) | 1997-12-31 |
DE69706823D1 (en) | 2001-10-25 |
GB9613021D0 (en) | 1996-08-28 |
CA2228492C (en) | 2007-05-08 |
PL325122A1 (en) | 1998-07-06 |
DE69706823T2 (de) | 2002-04-11 |
ZA975380B (en) | 1998-01-05 |
EP0853616A1 (en) | 1998-07-22 |
EA199800215A1 (ru) | 1998-08-27 |
HUP9902026A3 (en) | 2000-07-28 |
JPH11511761A (ja) | 1999-10-12 |
CN1198158A (zh) | 1998-11-04 |
EP0853616B1 (en) | 2001-09-19 |
AU3094197A (en) | 1998-01-14 |
NO980718L (no) | 1998-04-08 |
WO1997049689A1 (en) | 1997-12-31 |
HUP9902026A2 (hu) | 2000-04-28 |
AR008614A1 (es) | 2000-02-09 |
MX9801408A (es) | 1998-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1700048I1 (hu) | Szubsztituált 3-cianokinolinok mint protein tirozin kinázok inhibitorai | |
IL127796A0 (en) | Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors | |
GB9604361D0 (en) | 4-Substituted pyrrolopyrimidine compounds as tyrosine kinase inhibitors | |
AU3693697A (en) | Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors | |
GB9501567D0 (en) | Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors | |
IL137041A0 (en) | Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors | |
GB9507298D0 (en) | Substituted indolylmethylene-oxindale analogues as tyrosine kinase inhibitors | |
AU2396897A (en) | 5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick | |
HK1035188A1 (en) | Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors | |
EG24381A (en) | Tyrosine kinase inhibitors | |
AU7289696A (en) | Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors | |
HUP9901155A3 (en) | Quinazoline derivatives as vegf inhibitors | |
AU8689298A (en) | Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors | |
IL134013A (en) | Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors | |
AU3766897A (en) | Fused heterocyclic compounds as protein tyrosine kinase inhibitors | |
EP1161433A4 (en) | TYROSINE KINASE INHIBITORS | |
HU9700344D0 (en) | Substituted quinazoline derivatives | |
HK1049154A1 (zh) | 作為酪氨酸激酶抑制劑的2-吡唑啉-5-酮 | |
IL123124A0 (en) | Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors | |
PL331562A1 (en) | Derivatives of tetraquinoline as antagonists of eaa | |
GB9611797D0 (en) | Substituted quinolylmethylen-oxindole analogues as tyrosine kinase inhibitors | |
GB9610964D0 (en) | Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors | |
GB9600997D0 (en) | N-indolinyl-pyridopyrimidines as tyrosine kinase inhibitors | |
GB9524131D0 (en) | Pyrido-pyrimidine compounds as tyrosine kinase inhibitors |